| Type | Title | Date Released | |
|---|---|---|---|
6-K | Jin Medical International Ltd. Completes Transfer of Kangma Equity | ||
SCHEDULE 13D/A | Wang Erqi (Filed by) | ||
6-K | Jin Medical International Completed Acquisition of Huaxia Qiying via VIE Agreements | ||
6-K | Jin Medical International Enters into VIE Control Master Acquisition Agreement to Acquire Huaxia Qiying and Related Assets | ||
SCHEDULE 13D | Wang Erqi (Filed by) | ||
SCHEDULE 13G | NOVASTRALIST HORIZON LTD (Filed by) | ||
6-K | Jin Medical International Ltd. Completes Acquisition of Beijing Tongsheng Technology and Reports Fiscal 2026 First Half Results | ||
6-K | Jin Medical International Ltd. Announces Shareholder Approval of Voting Rights Increase, Share Repurchase, and Capital Restructuring | ||
3 | XUE NING (Reporting) | ||
6-K | Jin Medical International Ltd. Announces Board of Director Changes | ||
6-K/A | Jin Medical International Ltd. Announces Shareholder Meetings to Approve Voting Rights Changes, Share Repurchase, and Capital Increase | ||
6-K | Jin Medical International Ltd. Announces Shareholder Meetings to Approve Voting Rights Changes, Share Repurchase, and Capital Increase |
